This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on Web of Science (1)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

A. McLeod-Bryant Stephen, MD
Department of Psychiatry and Behavioral Sciences Medical University of South Carolina 171 Ashley Ave Charleston, SC 29425

Arch Gen Psychiatry. 1992;49(2):164-165.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

The reports by Van Putten et al¹ and Levinson et al² in the August 1990 issue of the ARCHIVES extend our knowledge of the appropriate dosages for neuroleptic medications in the treatment of psychotic illnesses.

There are some unanswered questions that I hope the authors can address in greater detail. In both reports, the populations studied were largely black. This could provide specific answers to important treatment issues related to black patients diagnosed as schizophrenic. For instance, it has been reported that black patients respond to neuroleptic medications differently than white patients do.³ It has also been suggested that black patients may be misdiagnosed as schizophrenic at a significantly higher rate than white patients do. Jones and Gray⁴ say that this occurs primarily in black patients with bipolar disorders who are misdiagnosed as schizophrenic.

Given these findings, were there significant racial differences in treatment . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?